The Valley Desk

NCT06657859 · Interventional trial

Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients

Overall registry status Enrolling by invitation

Phase 2

Conditions Phosphomannomutase 2 Deficiency, Pmm2-CDG

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov